Characterization of habits and crystalline modification of solids and their pharmaceutical applications.
暂无分享,去创建一个
[1] E. Nelson,et al. Physicochemical properties of drugs that control absorption rate after subcutaneous implantation. , 1962, The Journal of pharmacology and experimental therapeutics.
[2] J. Freyhof,et al. Physiochemical factors influencing the absorption of the anhydrous and trihydrate forms of ampicillin. , 1968, Current therapeutic research, clinical and experimental.
[3] Practical optical crystallography , 1965 .
[4] M. Hagan. Clathrate inclusion compounds , 1962 .
[5] Alan Holden,et al. Crystals and crystal growing , 1960 .
[6] B. Pedersen. NMR in Hydrate Crystals: Correction for Vibrational Motion , 1964 .
[7] R. Tawashi,et al. Inhibited dissolution of drug crystals by certified water-soluble dyes. II. , 1971, Journal of pharmaceutical sciences.
[8] H. Mcadie. THERMAL DECOMPOSITION OF MOLECULAR COMPLEXES: I. UREA-n-PARAFFIN INCLUSION COMPOUNDS , 1962 .
[9] R. Kahn,et al. Crystal structure of cyclohexane I and II , 1973 .
[10] J. Guillory,et al. Polymorphism in sulfanilamide-d4. , 1970, Journal of pharmaceutical sciences.
[11] J. H. Rayner,et al. 67. Structure of molecular compounds. Part X. Crystal structure of the compound of benzene with an ammonia–nickel cyanide complex , 1952 .
[12] L. S. Shenouda. Various species of sulfathiazole form I. , 1970, Journal of pharmaceutical sciences.
[13] H. Kuwano,et al. Polymorphism of Long-chain Esters of Chloramphenicol. I: On Transition@@@転移について , 1961 .
[14] A. Aguiar. Dilatometric behavior of polymorphic forms of chloramphenicol palmitate. , 1969, Journal of pharmaceutical sciences.
[15] M. Kuhnert-Brandstätter,et al. Polymorphie und Mischkristallbildung bei Sulfonamiden und verwandten Verbindungen , 1969 .
[16] P. E. Olesen,et al. Crystallization of Gramicidin , 1959, Nature.
[17] H. M. Powell. 15. The structure of molecular compounds. Part IV. Clathrate compounds , 1948 .
[18] A. A. Silvidi,et al. Motion of the H2O Molecule in Barium Chlorate Monohydrate , 1963 .
[19] R. J. Cross,et al. Clathration as a Practical Method for Handling Dimethylmercury , 1973, Nature.
[20] D. Saville,et al. Aspirin dissolution: polymorphism, crystal habit or crystal defects , 1971, The Journal of pharmacy and pharmacology.
[21] L. J. Ravin,et al. Physical-chemical evaluation of 3-(3-hydroxy-3-methylbutylamino)-5-methyl-as, triazino [5,6-b] indole (SK&F 30097). , 1970, Journal of pharmaceutical sciences.
[22] H. M. Powell. 64. The structure of molecular compounds. Part VIII. The compound of krypton and quinol , 1950 .
[23] J. Biles,et al. Effect of crystallizing solvent on absorption rates of steroid implants , 1964 .
[24] J. V. D. Waals. The statistical mechanics of clathrate compounds , 1956 .
[25] J. Biles,et al. Isolation and characterization of some solid phases of fluprednisolone. , 1971, Journal of pharmaceutical sciences.
[26] A. Parker,et al. Polymorphism of cephaloridine , 1968, The Journal of pharmacy and pharmacology.
[27] J. Whetstone. 945. Crystal symmetry, and the adsorption of dyes by growing crystals. Part I. Ammonium nitrate IV , 1956 .
[28] R. Rudman,et al. Polymorphism of the crystalline methylchloromethane compounds. III. Differential scanning calorimetric study , 1970 .
[29] P. Michel,et al. Polymorphisme du p-chlorophénol. I. Structure cristalline et morphologie de la forme stable , 1973 .
[30] J. E. Carless,et al. Application of differential scanning calorimetry to the study of sulphathiazole crystal forms , 1969, The Journal of pharmacy and pharmacology.
[31] W. Mccrone,et al. Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.
[32] M. Kuhnert-Brandstätter. Thermomicroscopy in the analysis of pharmaceuticals , 1971 .
[33] J. Biles,et al. Comparison of dissolution rates of different crystalline phases of fluprednisolone by in vitro and in vivo methods. , 1971, Journal of pharmaceutical sciences.
[34] C. Courseille,et al. Structure cristallines et moléculaires de trois formes polymorphes de l'oestrone , 1973 .
[35] R. Hatcher. THE UNITED STATES PHARMACOPEIA. , 1908 .
[36] S. Khalil,et al. Sulphamethoxydiazine crystal forms , 1971, The Journal of pharmacy and pharmacology.
[37] L. Pauling. THE HYDRATE MICROCRYSTAL THEORY OF GENERAL ANESTHESIA* , 1964, Anesthesia and analgesia.
[38] R. Roy,et al. Sulfur Melting and Polymorphism under Pressure: Outlines of Fields for 12 Crystalline Phases , 1969, Science.
[39] T. Nagai,et al. Dissolution Phenomena of Organic Medicinals involving Simultaneous Phase Changes , 1969 .
[40] J. E. Carless,et al. The polymorphism of aspirin , 1970, The Journal of pharmacy and pharmacology.
[41] R. E. Marsh,et al. The Structure of Chlorine Hydrate. , 1952, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Bugg,et al. Crystal structure of calcium chloride tetrahydrate , 1973 .
[43] J. W. Shell. Crystallographic Data. 99. Hydrocortisone Acetate , 1955 .
[44] R. Pfeiffer. Aspirin polymorphism questioned , 1971, The Journal of pharmacy and pharmacology.
[45] Y. Tsuda,et al. Dissolution Behavior of Solid Drugs. III. Determination of the Transition Temperature between the Hydrate and Anhydrous Forms of Phenobarbital by Measuring Their Dissolution Rates , 1973 .
[46] R. Bhattacharjee,et al. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension. , 1971, Journal of Pharmacy and Science.
[47] S. Khalil,et al. Effect of additives on the kinetics of interconversion of sulphamethoxydiazine crystal forms , 1973, The Journal of pharmacy and pharmacology.
[48] J. Guillory,et al. Polymorphism in sulfonamides. , 1972, Journal of pharmaceutical sciences.
[49] E. Teller,et al. ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .
[50] K. Sekiguchi,et al. Dissolution Behavior of Solid Drugs. II. Determination of the Transition Temperature of Sulfathiazole Polymorphs by Measuring the Initial Dissolution Rates , 1973 .
[51] 63. The structure of molecular compounds. Part VII. Compounds formed by the inert gases , 1950 .
[52] A J Aguiar,et al. Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid. , 1969, Journal of pharmaceutical sciences.
[53] E. Shefter,et al. DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS. , 1963, Journal of pharmaceutical sciences.
[54] R. Tawashi,et al. Aspirin: Dissolution Rates of Two Polymorphic Forms , 1968, Science.
[55] A. C. Marshall,et al. Crystalline Modifications of Ampicillin , 1965, Nature.
[56] J. Randall,et al. Atomic Physics and Related Subjects.: Communications to Nature.: The Diffraction of X-Rays by Vitreous Solids and its Bearing on their Constitution. , 1930, Nature.
[57] S. Lin. Preformulation investigation. II. Dissolution kinetics and thermodynamic parameters of polymorphs of an experimental antihypertensive. , 1972, Journal of pharmaceutical sciences.
[58] J. Biles. SOME CRYSTALLINE MODIFICATIONS OF THE TERT-BUTYLACETATES OF PREDNISOLONE AND HYDROCORTISONE. , 1963, Journal of pharmaceutical sciences.
[59] W. Mccrone,et al. Solid-state chemistry of cromolyn sodium (disodium cromoglycate). , 1971, Journal of pharmaceutical sciences.
[60] R. Hoff,et al. The Sulfur Hexafluoride Clathrate of Dianin's Compound (4-p-Hydroxyphenyl-2,2,4-trimethylchroman): Preparation, Characterization and Thermal Decomposition , 1960 .
[61] F. E. Roberts,et al. Effect of Crystalline Form on the Air-Oxidation of Steroidal 11β-ols to 11-ones , 1969 .
[62] R. Mesley. The polymorphism of sulphathiazole , 1971, The Journal of pharmacy and pharmacology.
[63] M. Miyamoto,et al. Differential Scanning Calorimetry of Chloramphenicol Palmitate and the Phase-Transitional Behavior of Chloramphenicol Palmitate observed during the Preparation of Its Oral Suspension , 1973 .
[64] H. M. Powell. New Procedures for Resolution of Racemic Substances , 1952, Nature.
[65] The National Formulary , 1945 .
[66] R. Tawashi. Gastrointestinal absorption of two polymorphic forms of aspirin , 1969, The Journal of pharmacy and pharmacology.
[67] M. Kuhnert-Brandstätter,et al. Zur Unterscheidung von lösungsmittelhaltigen pseudopolymorphen Kristallformen und polymorphen Modifikationen bei Steroidhormonen. I , 1968 .
[68] P. Gasser,et al. Solvates and polymorphic modifications of steroid hormones. I , 1971 .
[69] S. Khalil,et al. Kinetics of interconversion of sulphamethoxydiazine crystal forms , 1972, The Journal of pharmacy and pharmacology.
[70] G. Pake. Nuclear Resonance Absorption in Hydrated Crystals: Fine Structure of the Proton Line , 1948 .
[71] J. Whetstone. The crystal habit modification of inorganic salts with dyes. Part 1.—General considerations , 1955 .
[72] L. Pauling. A molecular theory of general anesthesia. , 1961, Science.
[73] T. Nagai,et al. Dissolution Kinetics of Barbital Polymorphs , 1969 .
[74] S. Khalil,et al. GI absorption of two crystal forms of sulfameter in man. , 1972, Journal of pharmaceutical sciences.